Chronic Disease
Management Market Research Report: By Solution (Educational Solution,
Implementation Solution, Consulting Solution and others), Delivery Mode
(Cloud-Based, On-Premises and Web-Based), Application (Arthritis,
Cardiovascular Disease, Cancer, Diabetes and others), End-User (Providers,
Payers) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) -
Forecast till 2025
Global Chronic Diseases Management Market
Size Driven by the Rising Demand for Advanced Treatment Methods
According to the
report by Market Research Future (MRFR), the global Chronic Diseases Management Market Size is predicted to reach a remarkable market
valuation at a 17.50% CAGR over the forecast period.
The market is
influenced by multiple driving factors such as the growing prevalence of
chronic diseases such as diabetes, severe cardiovascular disorders, and others,
along with the increasing demand for enhanced treatment methods. Additionally,
rapidly advancing technologies l and increasing investments towards research
and development activities taking place in the healthcare sector is expected to
augment the scope of opportunities for market players.
Segmental Analysis
The global market
for chronic diseases management is segmented based on service types,
application, deployment, and end-user.
Based on service
type, the Chronic Diseases Management Market Size has been segmented into
consulting service, educational service, implementation service, and others.
Based on
application, the market for chronic diseases management has been segmented into
asthma, cardiovascular, cancer, diabetes, stroke, and others.
Based on deployment,
the Chronic Diseases Management Market Size has been segmented into
cloud-based, on-premise, and web-based.
Based on end-user,
the market for chronic diseases management has been segmented into payer and
provider.
Browse Complete
Report : https://www.marketresearchfuture.com/reports/chronic-disease-management-market-981
Regional Analysis
Based on the region,
the global Chronic Diseases Management Market Size has been segmented into the
Americas (North and Latin America), Europe, Asia Pacific (APAC), and the Middle
East and Africa.
The Americas account
for the dominant region in the global Chronic Diseases Management Market Size
and is slated to retain its leading market share over the forecast period. This
has been accredited to the increasing prevalence of chronic diseases, and
unhealthy lifestyles and diets of consumers in the region during the assessment
period. Additionally, the high healthcare expenditure by the government to
ensure superior quality medical facilities for consumers is also a contributing
factor to the Chronic Diseases Management Market Size in the region over the
review period.
Europe accounts for
the second-largest region in the global Chronic Diseases Management Market Size
and is likely to maintain its market standing over the forecast period. The
increasing government support in the form of expenditure towards research and
development activities is expected to drive the demand for chronic diseases
management during the evaluation period.
The Asia Pacific has
been assessed as the fastest growing region in the global Chronic Diseases
Management Market Size. This is attributed to the increasing prevalence of
chronic diseases in the region, along with growing demand for technologically
advanced treatment methods, which creates a vast scope of opportunities for
market players in emerging economies such as India, China, and Japan. The
increase in government efforts to enhance the healthcare sector in the region
is also expected to impact the market over the review period positively.
The Middle East and
Africa region is accounted for the smallest market share through the forecast
period, owing to the poor economic development, technological advancements, and
political unrest in Africa. Nonetheless, increasing initiatives by governments
and nonprofit organizations to provide primary medical facilities to consumers
is assessed as a driving factor for the market over the evaluation period. The
gradual, moderate growth of the market in the region is also attributed to the
growing medical improvements and healthcare infrastructure in Middle Eastern
developing countries such as Kuwait, Saudi Arabia, and the United Arab
Emirates.
Key Players
The key players
identified in the global Chronic Diseases Management Market Size are Allscripts
Healthcare Solutions, Inc. (U.S.), AxisPoint Health (U.S.), Epic
Corporation Inc (U.S.), Harmony Information Systems, Inc. (U.S.), HealthSmart
Holdings, Inc (U.S.), i2i Systems, Inc (U.S.), Infosys Limited (India),
Pegasystems Inc. (U.S.), Phytel Inc (U.S.), TriZetto Corporation (U.S.),
Wellcentive, Inc, (Georgia), Medecision, Inc (U.S.), ZeOmega Inc. (U.S.).
Industry News
June 2019 – Houston
Methodist researchers reported a successful drug delivery of two chronic
disease medicines in the form of continuous, predetermined dosages with the use
of a nanochannel delivery system (nDS)
medical implant which was remote-controlled with Bluetooth technology.
June 2019 – Innomar
Strategies, a leading healthcare service provider, launched a
Chronic diseases management platform
called Chronically Simple for Canadian patients to register diagnostic images,
medical records, and test results.
No comments:
Post a Comment